InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.00
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,985.38
(
-0.19%
)
Post# of 129054
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bine646

Send PM Follow Ignore
Followers 1
Posts 237
Boards Moderated 0
Alias Born 07/30/2012

bine646

Re: newmedman post# 102933

Thursday, 08/22/2013 12:03:40 AM

Thursday, August 22, 2013 12:03:40 AM

Post# of 129054
This is off of their website
"Cannabis Science's research of CS-TATI-1 will be targeted to newly diagnosed patients infected with drug resistant virus, treatment-experienced patients with drug-resistant HIV strains, and those intolerant of currently available therapies"

Sounds like they are trying to sell an HIV cure thru misleading deceitful PRs. Good thing they are not filing those quarters, after 86 million in losses, majority in 2012- could be in trouble. Gullible investors should beware- cbds work, cbis doesnt
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up